Silence Therapeutics PLC
Company Profile
Business description
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene’s message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risk of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.Silence Therapeutics PLC is a biotechnology company in the United Kingdom. It uses its RNA technology to develop drugs to address genetic disorders.
Contact
72 Hammersmith Road
London W14 8TH
GBRT: +44 2034576900
E: info@silence-therapeutics.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2023
Employees
122
Stocks News & Analysis
stocks
Despite rally this A-REIT remains undervalued
stocks
We advise waiting for a pullback before investing in the world's biggest company
stocks
7 charts on the AI stock boom one year after ChatGPT’s launch
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,336.10 | 51.00 | 0.70% |
| CAC 40 | 7,332.59 | 13.56 | -0.18% |
| DAX 40 | 16,404.76 | 7.24 | 0.04% |
| Dow JONES (US) | 36,204.44 | 41.06 | -0.11% |
| FTSE 100 | 7,512.96 | 16.39 | -0.22% |
| HKSE | 16,646.05 | 184.25 | -1.09% |
| NASDAQ | 14,185.49 | 119.54 | -0.84% |
| Nikkei 225 | 33,231.27 | 200.24 | -0.60% |
| NZX 50 Index | 11,324.67 | 43.14 | -0.38% |
| S&P 500 | 4,569.78 | 24.85 | -0.54% |
| S&P/ASX 200 | 7,124.70 | 51.50 | 0.73% |
| SSE Composite Index | 3,022.91 | 8.72 | -0.29% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Pilbara Minerals Ltd PLS | 3.53 | 0.08 | -2.22% |
| Telstra Group Ltd TLS | 3.79 | 0.00 | 0.00% |
| Transurban Group TCL | 12.97 | 0.05 | 0.39% |
| South32 Ltd S32 | 3.12 | 0.03 | 0.97% |
| Evolution Mining Ltd EVN | 4.14 | 0.10 | 2.48% |
| Scentre Group SCG | 2.71 | 0.04 | 1.50% |
| Insurance Australia Group Ltd IAG | 5.83 | 0.11 | -1.85% |
| Santos Ltd STO | 6.82 | 0.08 | -1.16% |
| Incitec Pivot Ltd IPL | 2.87 | 0.04 | -1.37% |
| BHP Group Ltd BHP | 47.14 | 0.80 | 1.73% |